James Charlton
Plus aucun poste en cours
Profil
James Charlton served as President & Chief Executive Officer at Luminor Medical Technologies, Inc. in 2005 and 2007.
He also worked as Vice President-Research at Medicure, Inc. and as a Professor at the University of Manitoba.
Charlton earned a doctorate degree from the University of Western Ontario.
Anciens postes connus de James Charlton
| Sociétés | Poste | Fin |
|---|---|---|
Luminor Medical Technologies, Inc.
 Luminor Medical Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Luminor Medical Technologies, Inc. engages in acquiring, developing and commercializing non-invasive technologies for unmet clinical needs. It develops technology programs: Scout DS Diabetes Screen, PreVu Skin Cholesterol Test for fiabetes, and coronary artery disease. The company was founded on June 27, 1998 and is headquartered in Toronto, Canada. | President | 28/07/2005 |
| MEDICURE INC. | Directeur Technique/Scientifique/R&D | 20/05/2011 |
| University of Manitoba | Corporate Officer/Principal | - |
Luminor Medical Technologies, Inc.
Luminor Medical Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Luminor Medical Technologies, Inc. engages in acquiring, developing and commercializing non-invasive technologies for unmet clinical needs. It develops technology programs: Scout DS Diabetes Screen, PreVu Skin Cholesterol Test for fiabetes, and coronary artery disease. The company was founded on June 27, 1998 and is headquartered in Toronto, Canada. | President | 25/11/2009 |
Formation de James Charlton
| University of Western Ontario | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MEDICURE INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Luminor Medical Technologies, Inc.
Luminor Medical Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Luminor Medical Technologies, Inc. engages in acquiring, developing and commercializing non-invasive technologies for unmet clinical needs. It develops technology programs: Scout DS Diabetes Screen, PreVu Skin Cholesterol Test for fiabetes, and coronary artery disease. The company was founded on June 27, 1998 and is headquartered in Toronto, Canada. | Commercial Services |
